Skip to content

Effects of a cognitive stimulation program for people with dementia in nursing homes

Effects of a cognitive stimulation program for people with dementia in nursing homes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007720
Enrollment
60
Registered
2015-02-04
Start date
2014-07-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F01 F02 F03

Interventions

Group 1: Intervention group: NEUROvitalis sinnreich is a neuropsychological, cognitive stimulation program for persons with mild to moderate dementia. The program is completely structured and includes

Sponsors

Universität Vechta, Institut für Gerontologie und Center für Neuropsychologische Diagnostik & Intervention (CeNDI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Persons with dementia, residing in nursing homes Mild to moderate dementia, operationalized by the MMST: 10-25 points German as native language or a sufficient knowledge of german language Intact, slightly impaired or corrected eyesight and hearing ability Persons, who are able to participate in a cognitive stimulation program Persons, who give their written consent to participate in the study: - by the person itself. - if capacity for consent is limited, by a legal representative.

Exclusion criteria

Exclusion criteria: Persons, who suffer from a life-threatening disease Persons, with drug or alcohol abuse (at present or in the past)

Design outcomes

Primary

MeasureTime frame
Effects on cognitive functions (ADAS-Cog) and psychological and behavioural symptoms (Neuropsychiatric Inventory – Version for Nursing Homes) The primary outcomes will be assessed at T0 (pretest), T1 (posttest after the intervention respectively after the 8 weeks without intervention) and T2 (follow-up 6 weeks after the posttest).

Secondary

MeasureTime frame
Effects on quality of life (QoL-AD and QoL-AD Proxy) and activities of daily living (ADCS-ADL Scale) The secondary outcomes will be assessed at T0 (pretest), T1 (posttest after the intervention respectively after the 8 weeks without intervention) and T2 (follow-up 6 weeks after the posttest).

Countries

Germany

Contacts

Public ContactJennifer Liesk

Universität Vechta, Institut für Gerontologie und Center für Neuropsychologische Diagnostik & Intervention (CeNDI)

jennifer.liesk@uni-vechta.de+49 4441 15 731

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026